Mobile Menu

Search Results

Search results for: ctDNA

ctDNA Tests for Early Cancer Detection – Are We There Yet?

It is well established that detecting and diagnosing cancer earlier significantly improves patient outcomes. Therefore, the identification of cancer biomarkers […]

Evaluation of ctDNA assays for precision oncology

An international team has reported findings from an independent assessment of five commercially available ctDNA assays as a method to […]

Beyond companion diagnostics – what next for ctDNA liquid biopsy in the NHS?

Liquid biopsy has the promise to revolutionise cancer care and treatment, allowing the detection of rare cell types with a […]

ctDNA informs treatment in BRAF-mutated melanoma

Researchers find that cell-free circulating tumour DNA (ctDNA) analyses before and during treatment could help guide selection of therapy for […]

NSCLC: Implementing ctDNA analysis in the clinic

A recent review, published in Cancers, has summarised the current landscape of ctDNA analysis in clinical practice as well as […]

ctDNA and metabolites in CSF serve as novel biomarkers for CNS germ cell tumours

Researchers have validated the use of circulating tumour DNA (ctDNA) and metabolites in cerebrospinal fluid (CSF) as potential biomarkers for […]

Clinical Trials – What is holding liquid biopsy back?

This feature is written using content from our recently published Liquid Biopsy report, which you can read in full by […]

Liquid Biopsy ONLINE

Interested in expanding your knowledge of liquid biopsies via engaging, expert-led webinars? Then don’t miss our latest series, Liquid Biopsy […]

Using Urine to Detect Bladder Cancer Biomarkers: A Multi-Omics Approach

Biomarker detection is a fundamental requirement for early cancer detection. The rapidly developing field of multi-omics has the potential to […]

Cancer Diagnostics ONLINE: Detection in Time for Action

Thursday 12th, 19th and 26th October at 3pm BST / 4pm CET / 10am EDT  Early diagnosis of cancer is […]